Contemporary Pediatrics week in review: CDC recommendation for RSV, FDA approved eye drops, and more
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Contemporary Pediatrics week in review: CDC recommendation for RSV, FDA approved eye drops, and more | Image Credit: © Contemporary Pediatrics - © Contemporary Pediatrics - stock.adobe.com.
Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, September 25 to Friday, September 29, 2023) and click on each link to read and watch anything you may have missed.
1.) CDC recommends Pfizer’s maternal RSV vaccine to protect newborns
Ahead of the first fall and winter virus seasons in which vaccines are available for COVID-19, influenza, and respiratory syncytial virus (RSV), the Centers for Disease Control and Prevention is recommending Pfizer’s maternal vaccine to protect newborns from severe RSV illness.
Click here to read the full article.
2.) FDA approves phentolamine ophthalmic solution 0.75% eye drops for pharmacologically-induced mydriasis
Results from the phase 3 MIRA-4 pediatric trial demonstrated a favorable safety and tolerability profile with no reported adverse events. Rupa Wong, MD, offers thoughts on the approval, and why it may not change day-to-day practice when it comes to the pediatric population.
Click here for the full article.
3.) Will FDA-approved phentolamine ophthalmic solution 0.75% eye drops impact pediatric care?
In this Contemporary Pediatrics® interview, Rupa Wong, MD, discusses the recent FDA approval of phentolamine ophthalmic solution 0.75% eye drops to treat pharmacologically-induced mydriasis, and how this could impact the treatment landscape for the pediatric population. [Editor's note: RYZUMVI was previously known as Nyxol, which is referenced in the interview.]
Click here to watch the full interview.
4.) Evaluating pediatric ED readiness and racial, ethnic disparities in mortality
Peter C. Jenkins, MD, MSc, details his study recently published in JAMA Network Open, evaluating associations between pediatric emergency department readiness and mortality, and if children of all races benefited equitably.
Click here for the full Q+A interview.
5.) COVID-19 does not precipitate type 1 diabetes in children, study finds
The number of children who received a T1D diagnosis did not differ from children with and without SARS-CoV-2 infection.
The Role of the Healthcare Provider Community in Increasing Public Awareness of RSV in All Infants
April 2nd 2022Scott Kober sits down with Dr. Joseph Domachowske, Professor of Pediatrics, Professor of Microbiology and Immunology, and Director of the Global Maternal-Child and Pediatric Health Program at the SUNY Upstate Medical University.
